240 related articles for article (PubMed ID: 30803100)
21. Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis.
Enomoto N; Naoi H; Aono Y; Katsumata M; Horiike Y; Yasui H; Karayama M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
Ther Adv Respir Dis; 2020; 14():1753466620935774. PubMed ID: 32600180
[TBL] [Abstract][Full Text] [Related]
22. Preoperative use of pirfenidone and reduced risk of postoperative severe respiratory complications in patients with idiopathic pulmonary fibrosis: Propensity score-matched analysis using a nationwide database in Japan.
Urushiyama H; Jo T; Hasegawa W; Ando T; Sakamoto Y; Uda K; Matsui H; Fushimi K; Yasunaga H; Nagase T
Respirology; 2021 Jun; 26(6):590-596. PubMed ID: 33870611
[TBL] [Abstract][Full Text] [Related]
23. Survival from an Acute Exacerbation of Idiopathic Pulmonary Fibrosis with or without Direct Hemoperfusion with a Polymyxin B-immobilized Fiber Column: A Retrospective Analysis.
Oishi K; Aoe K; Mimura Y; Murata Y; Sakamoto K; Koutoku W; Matsumoto T; Ueoka H; Yano M
Intern Med; 2016; 55(24):3551-3559. PubMed ID: 27980253
[TBL] [Abstract][Full Text] [Related]
24. Outcomes with newly proposed classification of acute respiratory deterioration in idiopathic pulmonary fibrosis.
Teramachi R; Kondoh Y; Kataoka K; Taniguchi H; Matsuda T; Kimura T; Yokoyama T; Yamano Y; Furukawa T; Sakamoto K; Hashimoto N; Hasegawa Y
Respir Med; 2018 Oct; 143():147-152. PubMed ID: 30261987
[TBL] [Abstract][Full Text] [Related]
25. Heterogeneity of incidence and outcome of acute exacerbation in idiopathic interstitial pneumonia.
Arai T; Kagawa T; Sasaki Y; Sugawara R; Sugimoto C; Tachibana K; Kitaichi M; Akira M; Hayashi S; Inoue Y
Respirology; 2016 Nov; 21(8):1431-1437. PubMed ID: 27460223
[TBL] [Abstract][Full Text] [Related]
26. Predictors of acute exacerbation in biopsy-proven idiopathic pulmonary fibrosis.
Kishaba T; Hozumi H; Fujisawa T; Nei Y; Enomoto N; Sugiura H; Kitani M; Suda T
Respir Investig; 2020 May; 58(3):177-184. PubMed ID: 32205147
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of traditional Chinese medicine in patients with acute exacerbation of idiopathic pulmonary fibrosis: study protocol for randomized, controlled, exploratory clinical trial.
Hailong Z; Jiansheng L; Wen G; Lu W; Dong Z; Limin Z; Miao Z; Weixian L
Trials; 2022 Feb; 23(1):103. PubMed ID: 35109889
[TBL] [Abstract][Full Text] [Related]
28. Polymyxin B-immobilized fiber column (PMX) treatment for idiopathic pulmonary fibrosis with acute exacerbation: a multicenter retrospective analysis.
Abe S; Azuma A; Mukae H; Ogura T; Taniguchi H; Bando M; Sugiyama Y
Intern Med; 2012; 51(12):1487-91. PubMed ID: 22728479
[TBL] [Abstract][Full Text] [Related]
29. Recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis: A historically controlled study.
Sakamoto S; Shimizu H; Isshiki T; Sugino K; Kurosaki A; Homma S
Respir Investig; 2018 Mar; 56(2):136-143. PubMed ID: 29548651
[TBL] [Abstract][Full Text] [Related]
30. Survival in Idiopathic pulmonary fibrosis acute exacerbations: the non-steroid approach.
Papiris SA; Kagouridis K; Kolilekas L; Papaioannou AI; Roussou A; Triantafillidou C; Baou K; Malagari K; Argentos S; Kotanidou A; Karakatsani A; Manali ED
BMC Pulm Med; 2015 Dec; 15():162. PubMed ID: 26666385
[TBL] [Abstract][Full Text] [Related]
31. Time for Prevention of Idiopathic Pulmonary Fibrosis Exacerbation.
Richeldi L
Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2():S181-5. PubMed ID: 26595737
[TBL] [Abstract][Full Text] [Related]
32. Recombinant thrombomodulin for acute exacerbation in idiopathic interstitial pneumonias.
Arai T; Kida H; Ogata Y; Marumo S; Matsuoka H; Gohma I; Yamamoto S; Mori M; Sugimoto C; Tachibana K; Akira M; Edahiro R; Hamasaki T; Inoue Y;
Respirology; 2019 Jul; 24(7):658-666. PubMed ID: 30835911
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis.
Gui X; Qiu X; Tian Y; Xie M; Li H; Gao Y; Zhuang Y; Cao M; Ding H; Ding J; Zhang Y; Cai H
Int Immunopharmacol; 2019 May; 70():208-215. PubMed ID: 30851700
[TBL] [Abstract][Full Text] [Related]
34. Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic.
Tachikawa R; Tomii K; Ueda H; Nagata K; Nanjo S; Sakurai A; Otsuka K; Kaji R; Hayashi M; Katakami N; Imai Y
Respiration; 2012; 83(1):20-7. PubMed ID: 21912082
[TBL] [Abstract][Full Text] [Related]
35. Serum high-mobility group box 1 is associated with the onset and severity of acute exacerbation of idiopathic pulmonary fibrosis.
Yamaguchi K; Iwamoto H; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N
Respirology; 2020 Mar; 25(3):275-280. PubMed ID: 31270920
[TBL] [Abstract][Full Text] [Related]
36. Prognostic evaluation of serum ferritin in acute exacerbation of idiopathic pulmonary fibrosis.
Enomoto N; Oyama Y; Enomoto Y; Mikamo M; Karayama M; Hozumi H; Suzuki Y; Kono M; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
Clin Respir J; 2018 Aug; 12(8):2378-2389. PubMed ID: 29873202
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Factors in the Acute Exacerbation of Idiopathic Pulmonary Fibrosis: A Retrospective Single-center Study.
Atsumi K; Saito Y; Kuse N; Kobayashi K; Tanaka T; Kashiwada T; Inomata M; Kokuho N; Hayashi H; Kamio K; Fujita K; Abe S; Azuma A; Kubota K; Gemma A
Intern Med; 2018 Mar; 57(5):655-661. PubMed ID: 29151518
[TBL] [Abstract][Full Text] [Related]
38. Polymyxin-B hemoperfusion for acute exacerbation of idiopathic pulmonary fibrosis: serum IL-7 as a prognostic marker.
Tachibana K; Inoue Y; Nishiyama A; Sugimoto C; Matsumuro A; Hirose M; Kitaichi M; Akira M; Arai T; Hayashi S; Inoue Y
Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):113-22. PubMed ID: 22117502
[TBL] [Abstract][Full Text] [Related]
39. Early corticosteroid dose tapering in patients with acute exacerbation of idiopathic pulmonary fibrosis.
Anan K; Kataoka Y; Ichikado K; Kawamura K; Johkoh T; Fujimoto K; Tobino K; Tachikawa R; Ito H; Nakamura T; Kishaba T; Inomata M; Kamitani T; Yamazaki H; Ogawa Y; Yamamoto Y
Respir Res; 2022 Oct; 23(1):291. PubMed ID: 36289512
[TBL] [Abstract][Full Text] [Related]
40. Initial therapeutic dose of corticosteroid for an acute exacerbation of IPF is associated with subsequent early recurrence of another exacerbation.
Yamazaki R; Nishiyama O; Saeki S; Sano H; Iwanaga T; Tohda Y
Sci Rep; 2021 Mar; 11(1):5782. PubMed ID: 33707613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
